Congenital Heart Disease and Defects

My Settings
Relevant Content
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Extension follow-up studies address long-term questions beyond the parent...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Association Between Preschool Physical Activity and Health Care Use and Burden in Children With Congenital Heart Disease
Journal of the American Heart Association, Ahead of Print.
Background...
Magnetic Resonance Imaging–Based Psoas Muscle Volume as an Additional Risk Factor for Fontan Failure: A Prospective Cohort Study
Journal of the American Heart Association, Ahead of Print.
Background...
Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology
Journal of the American Heart Association, Ahead of Print.
Background...
Extracorporeal Membrane Oxygenation in the Interstage Period After Norwood and Related Stage I Palliations in Infants With Single Ventricle: A Systematic Review of Incidence, Risk Factors, and Outcomes
Journal of the American Heart Association, Volume 15, Issue 12, June 16, 2...
Fontan‐Related Lymphatic Complications: Incidence, Risk Factors, and Impact on Extracardiac Outcomes and Morbidity
Journal of the American Heart Association, Volume 15, Issue 12, June 16, 2...
Technical Success of Fetal Aortic Valvuloplasty in Relation to Center Volumes: A Report From the International Fetal Cardiac Intervention Registry
Circulation: Cardiovascular Interventions, Ahead of Print.
BACKGROUND...
Clinical Benefits of Medical Therapy in Adults With Congenital Heart Disease and Systemic Left Ventricular Presenting With Heart Failure With Reduced Ejection Fraction
Journal of the American Heart Association, Ahead of Print.
Background...
Genetic Testing in Congenital Heart Disease: From Microarray to Genome Sequencing
Circulation: Genomic and Precision Medicine, Ahead of Print.